Table 1.

miRNA differentially expressed in CRC cell lines.

	MEAN FOLD-CHANGE (LOG10 RQ)	CHROMOSOME LOCALIZATION	PUTATIVE TARGETS ASSOCIATED WITH COLORECTAL CARCINOGENESIS
hsa-miR-147	-4.56	9q32.3
hsa-miR-127	-4.27	14q32.31
hsa-miR-145	-4.13	5q32	TGFRII, APC
hsa-miR-370	-4.05	14q32.31	BAX, AKT1
hsa-miR-299	-3.90	14q32.31	B-CATENIN, CDKN1A
hsa-miR-199a	-3.80	1q24.3
hsa-miR-154*	-3.71	14q32.31	MLH1
hsa-miR-199-s	-3.64	19p13.2
hsa-miR-323	-3.56	14q32.31	MSH2
hsa-miR-154	-3.55	14q32.31
hsa-miR-134	-3.34	14q32.31
hsa-miR-342	-3.15	14q32.2
hsa-miR-199a*	-3.06	1q24.3
hsa-miR-137	-3.05	1p21.3	TGFRII
hsa-miR-368	-3.03	14q32.31
hsa-miR-130a	- 3.02	11q12.1	TGFRII
hsa-miR-214	-2.36	1q24.3	TP53, B-CATENIN, TGFRII, BAX, CDKN2B, EGFR
hsa-miR-337	- 2.25	14q32.31	CDKN2A
hsa-miR-125b	-2.20	11q24.1	VEGF, IGFRI, VEGFR
hsa-miR-199b	-2.19	9q34.11
hsa-miR-133a	-2.11	18q11.2	BAX, K-RAS
hsa-miR-26b	-1.82	2q35	APC
hsa-miR-133b	-1.66		K-RAS
hsa-miR-296	-1.61	20q13.32
hsa-miR-124b	1.42		MLH1
hsa-miR-338	1.63	17q25.3
hsa-miR-9*	1.68	5q14.3	TCF4, MSH2
hsa-let-7g	1.73	3p21.2	TGFRII
hsa-miR-372	1.76	19q13.42	TGFRII, SMAD2, MLH1, AKT1
hsa-miR-182*	1.77
hsa-miR-219	1.93	6p21.32	TGFRII
hsa-miR-205	2.21	1q32.2	K-RAS, SMAD4, MSH2, PTEN
hsa-miR-194	2.23	1q41
hsa-miR-142-3p	2.29		APC
hsa-miR-135a	2.36	3p21.2	MSH2
hsa-miR-215	2.42	1q41	IGFRI
hsa-miR-142-5p	2.51	17q23.2
hsa-miR-135b	2.90	1q32.1	MSH2
hsa-miR-141	3.28	12p13.31	APC, MSH2
hsa-miR-182	3.41	7q32.2	IGFRI
hsa-miR-200b	3.44	1p36.33	MLH1
hsa-miR-200c	3.64	12p13.31	MLH1, SMAD2
hsa-miR-96	3.64	7q32.2	K-RAS
hsa-miR-200a	3.73	1p36.33	MSH2
hsa-miR-203	3.77	14q32.33